LEOPARD syndrome 1: genes and variants
Explore variant evidence for LEOPARD syndrome 1 across 3 analyzed proteins (PTPN11, RAF1, BRAF). Linked ClinVar records include 22 pathogenic or likely pathogenic variants, 57 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to LEOPARD syndrome 1
PTPN11: Tyrosine-protein phosphatase non-receptor type 11
Its SHP2 phosphatase activity promotes RAS-MAPK signaling downstream of many receptor tyrosine kinases and cytokine receptors. Germline dysregulating variants cause Noonan-spectrum disorders, while somatic activating variants drive juvenile myelomonocytic leukemia and other cancers.
16 ClinVar pathogenic / likely pathogenic and 29 uncertain variants in PTPN11 have source records linked to LEOPARD syndrome 1. Association strength is not clinical gene validity.
RAF1: RAF proto-oncogene serine/threonine-protein kinase
It relays activated RAS signals to MEK and ERK and also participates in survival and developmental pathways. Germline activating variants cause Noonan syndrome and related RASopathies, while oncogenic activation contributes to selected cancers.
4 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in RAF1 have source records linked to LEOPARD syndrome 1. Association strength is not clinical gene validity.
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
2 ClinVar pathogenic / likely pathogenic and 23 uncertain variants in BRAF have source records linked to LEOPARD syndrome 1. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to LEOPARD syndrome 1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PTPN11 P491T | 491 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 P491L | 491 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 A72S | 72 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 V428L | 428 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 P491S | 491 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 R498W | 498 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 G503E | 503 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| BRAF K601Q | 601 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| BRAF K601I | 601 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| PTPN11 G60V | 60 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 E69V | 69 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 Y279S | 279 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 N308T | 308 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| RAF1 P261A | 261 | Pathogenic / likely pathogenic (★★) | |
| PTPN11 N58K | 58 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 A461S | 461 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| RAF1 G169R | 169 | Phorbol-ester/DAG-type | Pathogenic / likely pathogenic (★★) |
| RAF1 V263D | 263 | Pathogenic / likely pathogenic (★★) | |
| PTPN11 T2I | 2 | Pathogenic / likely pathogenic (★★) | |
| PTPN11 F71L | 71 | SH2 1 | Pathogenic / likely pathogenic (★) |
| PTPN11 A31G | 31 | SH2 1 | Pathogenic / likely pathogenic (★) |
| RAF1 T258R | 258 | Pathogenic / likely pathogenic (★) |
Which prediction tools work for LEOPARD syndrome 1
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- ESM1b (LLR): 97 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 91 out of 100
- EVE: 90 out of 100
- phyloP: 88 out of 100
- SIFT: 86 out of 100
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- RASopathy also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (51 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (44 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (29 pathogenic / likely pathogenic).
- Metachondromatosis also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (11 pathogenic / likely pathogenic).
- Monogenic short statue also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (6 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to RAF1 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (28 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to RAF1 variants; they fall in the same places as the LEOPARD syndrome 1 variants (14 pathogenic / likely pathogenic).
- Dilated cardiomyopathy 1NN also has ClinVar records linked to RAF1 variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (5 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to RAF1 variants; they fall partly in the same places as the LEOPARD syndrome 1 variants (4 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to BRAF variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (36 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (26 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (17 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (11 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the LEOPARD syndrome 1 variants (10 pathogenic / likely pathogenic).
Diseases related to LEOPARD syndrome 1
- RASopathy, also linked to BRAF, PTPN11 and RAF1
- Noonan syndrome, also linked to BRAF, PTPN11 and RAF1
- Noonan syndrome and Noonan-related syndrome, also linked to BRAF, PTPN11 and RAF1
- Noonan syndrome with multiple lentigines, also linked to BRAF and PTPN11
- Hypertrophic cardiomyopathy, also linked to BRAF
- Cardiofaciocutaneous syndrome, also linked to BRAF
- Cardio-facio-cutaneous syndrome, also linked to BRAF
- Acute myeloid leukemia, also linked to PTPN11
- Colorectal cancer, also linked to BRAF
- Non-small cell lung carcinoma, also linked to BRAF
- Costello syndrome, also linked to BRAF
- Melanoma, cutaneous malignant, also linked to BRAF
Frequently asked questions
Which genes have records linked to LEOPARD syndrome 1?
This view contains 3 analyzed proteins: PTPN11, RAF1, BRAF. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 22 pathogenic or likely pathogenic variants, 57 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 104 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center